Skip to Content

L-24 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)

Pill with imprint L-24 is White, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Macleods Pharmaceuticals Limited.

Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L-24

Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
L-24
Strength
200 mg / 300 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0106

Get help with Imprint Code FAQs.

Related Images for "L-24"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.